📈 Revenue History (4 Quarters)
🧮 LENZ Revenue Breakdown
Understanding Revenue
Revenue, also called sales or the "top line," represents the total income a company generates from its business activities before any costs are deducted. For LENZ, the trailing twelve month revenue is $24.9M.
Why Revenue Matters
Revenue is the foundation of all financial analysis. A company cannot have sustainable profits without revenue, and revenue growth often drives stock price appreciation. However, revenue alone doesn't tell the full story - it must be analyzed alongside profitability metrics.
LENZ's revenue growth rate of -49.26% (based on log-linear regression of 4 quarters) indicates significant revenue decline, which requires investigation.
Revenue vs Profitability Metrics
Free Cash Flow: $-87.4M →
The cash remaining after capital expenditures. High revenue with negative FCF may indicate heavy reinvestment or poor cash conversion.
Owner Earnings: $-86.9M →
Buffett's metric for true cash generation. Compares revenue's conversion to actual owner value.
Earnings Per Share: $-4.13 →
Net income per share. The bottom line result of all revenue after costs, taxes, and interest.
Net Income: $-126.0M
What remains after all expenses. Net margin shows what percentage of revenue becomes profit.
Price/Sales Ratio Analysis
LENZ's P/S ratio of 6.4x means investors pay $6.44 for every $1 of annual revenue. A P/S between 3-10 suggests investors expect continued growth and margin expansion.
Gross Margin: Revenue Quality
Gross margin of N/A shows how much of LENZ's revenue remains after direct costs.
Summary: LENZ Revenue Trend
LENZ THERAPEUTICS, INC. (LENZ) generated $24.9M in trailing twelve-month revenue, growing at -49.26% annually — a material decline Zyberno treats as a concern requiring investigation. Gross margin: N/A. For complete financial analysis, view the full LENZ stock report on Zyberno.
Frequently Asked Questions
What is LENZ's current revenue?
LENZ THERAPEUTICS, INC.'s trailing twelve month (TTM) revenue is $24.9M, growing at -49.26% annually — a material decline Zyberno treats as a concern requiring investigation.
Is LENZ's revenue growing?
LENZ THERAPEUTICS, INC. (LENZ) generated $24.9M in trailing twelve-month revenue, growing at -49.26% annually — a material decline Zyberno treats as a concern requiring investigation. Gross margin: N/A.
What is LENZ's gross margin?
LENZ's gross margin is N/A.
What is LENZ's Price/Sales ratio?
LENZ's P/S ratio is 6.4x, meaning the market values the company at 6.4 times its annual revenue.
How does revenue differ from profit?
Revenue is the total income before any expenses, while profit (net income) is what remains after all costs. LENZ's revenue is $24.9M with a net income of $-126.0M, showing a net profit margin of -506.3%.
📊 Full LENZ Stock Report →
See LENZ's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 LENZ Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 LENZ Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 LENZ Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 LENZ Earnings Surprise (SUE) →
See whether LENZ is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 LENZ Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 LENZ Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 LENZ Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 LENZ Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.